From the Nigeria Magazine Desk
Chinese neurotechnology company BrainCo is developing a wearable device designed to help people control their appetite by stimulating the brain, potentially introducing a new approach to weight management.
The device, which the company describes as an electronic alternative to GLP-1 weight-loss medications such as Wegovy and Zepbound, is being developed to influence hunger signals without requiring injections or medication.
According to BrainCo founding partner Nyx He, who spoke at the Bloomberg Tech London event, the company hopes to launch the technology within the next two to three years.
The product is expected to debut in China before expanding into the United States. It will reportedly have two versions: one designed for medical applications and another for everyday consumer use.
BrainCo is already involved in neurotechnology, producing brain-monitoring headsets aimed at addressing conditions such as attention-deficit/hyperactivity disorder (ADHD) and insomnia. The company also develops prosthetic and robotic hands.
Beyond its wearable technology, BrainCo has reportedly filed confidentially for an initial public offering (IPO) in Hong Kong and may explore brain implant technology in the future.
If successful, the appetite-control wearable could introduce another technology-driven approach to weight management, although its safety, effectiveness and clinical benefits will need to be established through appropriate testing.
The development highlights the growing intersection of neuroscience, healthcare and wearable technology, as companies explore new ways to influence human behaviour and improve health.
Source: Bloomberg Tech event remarks, as reported in a LinkedIn post.
